Menopausal Hormone Therapy and Bone Density Protection

Menopause marks a significant transition in a woman's life, bringing about various symptoms that many experience. Hot flashes, night sweats, and fatigue can greatly diminish quality of life, leading more women to consider hormone therapy. Recent studies suggest that hormone therapy not only alleviates menopausal symptoms but also has a positive impact on maintaining bone density.

Hormone Therapy Reduces Risk of Bone Density Loss

According to research presented at the annual meeting of the Endocrine Society (ENDO 2026) in Chicago, women who received menopausal hormone therapy had a 69% lower risk of bone density loss compared to those who did not. Researchers analyzed 387 postmenopausal women who underwent bone density tests between 2021 and 2025, with 33% receiving hormone therapy and the remaining 67% not.

• Women on hormone therapy: 69% reduced risk of bone density loss
• Spine and hips: Most common fracture sites in older women

A decline in bone density can lead to osteoporosis, resulting in fractures and reduced physical function. Therefore, these findings highlight a significant benefit of hormone therapy.

Expert Opinions and the Necessity of Treatment

Dr. Diego Espinoza-Peralta, who led the study, emphasized that "Menopausal hormone therapy can offer the important additional benefit of protecting bone health," and that it should be viewed as a treatment that can be actively considered. The study's results remained consistent even after accounting for various factors such as participants' age, duration of menopause, vitamin D levels, and smoking status.

These findings align with several previous studies, which have reported a 34% reduction in hip fracture risk and an approximately 30% reduction in overall fracture risk for women undergoing hormone therapy. This is crucial information for menopausal women.

Individual Risk Assessment and Treatment Decisions

However, hormone therapy is not suitable for all menopausal women. Experts caution that while hormone therapy can alleviate various symptoms like hot flashes, sleep disturbances, and joint pain, it may increase the risk of certain conditions, such as breast cancer, in some women. Therefore, the decision to undergo treatment should be made after a thorough consideration of an individual's health status and risk factors.

Especially for women in the early stages of menopause, the benefits of hormone therapy require careful evaluation. Dr. Espinoza-Peralta stated, "If clinicians more carefully evaluate the benefits of hormone therapy in early menopausal women, it could contribute to long-term health and improved quality of life."